- Published on: March 28, 2022
- 14:38
Havana, Mar 28 (Prensa Latina) NeuroEPO, Cuba's neuroprotective drug to counteract mild and moderate Alzheimer's disease, concluded phase II/III studies and a stage IV of progressive introduction of the product is being prepared, a scientific authority noted on Monday.